Cartherics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $300K

  • Investors
  • 2

Cartherics General Information

Description

Developer of gene-edited cell therapy technology designed to treat cancer and endometriosis through targeted immune cell approaches. The company offers an induced pluripotent stem cell-based platform that generates engineered natural killer cells and supports end-to-end discovery and clinical manufacturing, enabling the development of scalable, targeted immune therapies for oncology and women's health treatments across solid tumors and endometriosis indications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 Ferntree Place
  • Notting Hill, Victoria 3168
  • Australia
+61 1300
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 12 Ferntree Place
  • Notting Hill, Victoria 3168
  • Australia
+61 1300

Cartherics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cartherics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 18-Dec-2024 $300K Completed Generating Revenue
3. Later Stage VC (Series B) 01-Oct-2024 Completed Generating Revenue
2. Later Stage VC Completed Startup
1. Grant 27-Sep-2022 $5.4M Completed Startup
To view Cartherics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cartherics Patents

Cartherics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022220754-A1 Methods and compositions for generating stem cell-derived immune cells with enhanced function Pending 10-Feb-2021
CA-3211013-A1 Methods and compositions for generating stem cell-derived immune cells with enhanced function Pending 10-Feb-2021
EP-4291660-A1 Methods and compositions for generating stem cell-derived immune cells with enhanced function Pending 10-Feb-2021
EP-4291660-A4 Methods and compositions for generating stem cell-derived immune cells with enhanced function Pending 10-Feb-2021
JP-2024506067-A Methods and compositions for generating stem cell-derived immune cells with enhanced function Pending 10-Feb-2021 A61K40/31
To view Cartherics’s complete patent history, request access »

Cartherics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cartherics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
ScaleReady Corporation Minority
Australian Digital Health Agency Government
To view Cartherics’s complete investors history, request access »

Cartherics FAQs

  • When was Cartherics founded?

    Cartherics was founded in 2016.

  • Where is Cartherics headquartered?

    Cartherics is headquartered in Notting Hill, Australia.

  • What is the size of Cartherics?

    Cartherics has 37 total employees.

  • What industry is Cartherics in?

    Cartherics’s primary industry is Drug Discovery.

  • Is Cartherics a private or public company?

    Cartherics is a Private company.

  • What is Cartherics’s current revenue?

    The current revenue for Cartherics is .

  • How much funding has Cartherics raised over time?

    Cartherics has raised $10.5M.

  • Who are Cartherics’s investors?

    ScaleReady and Australian Digital Health Agency have invested in Cartherics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process